ArticleFrontiers in oncology2024

Survival analysis of recurrent ovarian cancer under different PARP inhibitor treatment patterns: a single-center retrospective study.

Jingtian Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.